We are live on
!
Find out more
TWM
Thrive Wealth Management Portfolio holdings
AUM
$787M
1-Year Est. Return
23.6%
This Fund
S&P 500
This Quarter
Est. Return
-2.65%
1 Year Est. Return
+23.6%
3 Year Est. Return
+73.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$671M
AUM Growth
-$9.87M
(-1.4%)
Cap. Flow
+$14.2M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
63.5%
Holding
261
New
23
Increased
88
Reduced
109
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$12.3M |
| 2 |
Vanguard Value ETF
VTV
|
+$5.95M |
| 3 |
Vanguard Growth ETF
VUG
|
+$866K |
| 4 |
Capital Group Municipal Income ETF
CGMU
|
+$803K |
| 5 |
IBM
IBM
|
+$802K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Collegium Pharmaceutical
COLL
|
+$941K |
| 2 |
Lockheed Martin
LMT
|
+$490K |
| 3 |
Danaher
DHR
|
+$480K |
| 4 |
Thermo Fisher Scientific
TMO
|
+$450K |
| 5 |
AstraZeneca
AZN
|
+$413K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.02% |
| 2 | Financials | 3.96% |
| 3 | Healthcare | 2.81% |
| 4 | Communication Services | 2.58% |
| 5 | Industrials | 2.23% |
Similar funds
FAMI
GCM
RBC
SBCM
SWIG
NEAM
JSL
LSPW
Thrive Wealth Management's Q1 2026 Portfolio in Review
As of Q1 2026, Thrive Wealth Management held 261 positions worth $671M, down 1.4% from $681M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Thrive Wealth Management's Q1 2026 filing shows 23 new, 88 increased, 109 reduced and 30 closed positions. Its largest new stake was Avantis International Equity ETF: 7,369 shares worth $625K. The largest sale was Collegium Pharmaceutical, an estimated $941K.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.6% a quarter earlier, followed by Financials and Healthcare.
- Thrive Wealth Management's largest Q1 2026 buy was Avantis International Equity ETF: 7,369 shares worth $625K.
- Thrive Wealth Management added most to Schwab US Large-Cap Growth ETF in Q1 2026, an estimated $12.3M increase.
- Thrive Wealth Management's biggest Q1 2026 reduction was Lockheed Martin, cutting an estimated $490K.
- Thrive Wealth Management fully exited Collegium Pharmaceutical in Q1 2026, selling an estimated $941K.
- Thrive Wealth Management's ten largest holdings make up 64% of its $671M portfolio in Q1 2026.
- Thrive Wealth Management opened 23 new positions and closed 30 in Q1 2026.
- Thrive Wealth Management's portfolio value fell 1.4% quarter-over-quarter to $671M.
Based on Thrive Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.